Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Zollinger-Ellison Syndrome 1Gastroesophageal Reflux 1Barrett Esophagus 1

Interventions

Esomeprazole 3Radiofrequency Ablation 2Endoscopy, Digestive System 2rofecoxib 1YF 476 1X-Rays 1Narrow Band Imaging 1Lansoprazole 1Endoscopy 1Diagnostic Imaging 1Dexlansoprazole 1Cryosurgery 1Blood Specimen Collection 1Biopsy 1Aspirin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
INDUSTRY × Barrett Esophagus × YF 476 × Clear all
NCT02597712 2021-04-12

YF476 in Barrett's Esophagus

Trio Medicines Ltd.

Phase 2 Completed
27 enrolled 15 charts
Gastrointestinal

Barrett Esophagus, Gastroesophageal Reflux

Data powered by HemOnc (CC BY 4.0) Colophon âš¡